Delivery Order SPE2DB22D2007-SPE2DB25FH9HR

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,048.26, is for the delivery of 100 tablets of Oxcarbazepine ER 150 mg, a medication used to treat seizures. This is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 24, 2025. The contract was awarded on January 23, 2025, and was not...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,436.26, is a delivery order for 4567008506 - OXCARBAZEPINE 300 MG/5 ML SUSP 250ML. It is a firm fixed-price contract with a completion date of January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,608.01 firm-fixed-price delivery order is for the supply of 4,565,933,418 units of Oxcarbazepine 600 mg tablets. The award has an ultimate completion date of September 26, 2024 and is not a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,449,031 units of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The delivery order, valued at $1,453.15, has a firm fixed price and a completion date of January 26, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,360.61 firm-fixed-price delivery order is for 4,559,723,046 tablets of the prescription medication Oxcarbazepine 600 mg. The contract has a completion date of January 26, 2023 and was awarded on January 25, 2023. There was no set-aside designation used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,090.18 Firm Fixed Price Delivery Order is for the supply of 4,566,615,636 units of OXCARBAZEPINE 600 MG TABLET 500S, with a completion date of December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,002.58, is for the delivery of Oxaprozin 600 mg tablets. It is a firm fixed-price delivery order contract with a completion date of September 20, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $7,223.90 firm fixed-price delivery order is for the supply of 250 ml bottles of the drug Trileptal, a medication used to treat certain types of seizures. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $2,063.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price delivery order, without any set-aside designation, and has an ultimate completion date of January 5, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and...
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,140.95 Firm Fixed Price Delivery Order is for the supply of Lamotrigine ER 300 mg tablets. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH9HR
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.73, is for the delivery of oxcarbazepine 300 mg/5 ml suspension, a generic anticonvulsant medication, with a completion date of February 25, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/1/25, 3:09 AM